Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2022 | Unmet clinical needs for muscle-invasive bladder cancer

Thomas Flaig • 17 Feb 2022
GU Cancers 2022
Bladder Cancer Genitourinary Cancer Urothelial Carcinoma

Thomas Flaig, MD, University of Colorado Anschutz Medical Campus, Aurora, CO, discusses the future challenges and unmet needs of urothelial carcinoma research. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.

More from Thomas Flaig

1:34
Management of toxicities with novel systemic therapies in UC
Thomas Flaig • 17 Feb 2022
1:25
SWOG S1314: overall survival results
Thomas Flaig • 17 Feb 2022
0:51
Future of urothelial carcinoma research
Thomas Flaig • 17 Feb 2022

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals